Arvinas (ARVN) Debt Ratio (2017 - 2026)
Arvinas (ARVN) posted quarterly Debt Ratio of 0.0 for Q1 2026, up 10.44% year-over-year from 0.0 in Q1 2025, and up 38.59% quarter-over-quarter from 0.0 in Q4 2025.
Powered by 
Analysis
Arvinas (ARVN) Debt Ratio (2017 - 2026) Analysis & Trends
Arvinas' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.0 for Q1 2026.
- In Q1 2026, Debt Ratio rose 10.44% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (up 10.44% YoY), while the FY2025 annual figure was 0.0, down 23.99% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.0, up from 0.0 in the prior quarter.
- The five-year high for Debt Ratio was 0.0 in Q3 2023, with the low at 0.0 in Q3 2024.
- The 5-year median for Debt Ratio is 0.0 (2022), against an average of 0.0.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio plunged 77.1% in 2022, then jumped 51.35% in 2023.
- Arvinas' Debt Ratio stood at 0.0 in 2022, then retreated by 22.2% to 0.0 in 2023, then advanced by 19.53% to 0.0 in 2024, then slipped by 23.99% to 0.0 in 2025, then soared by 38.59% to 0.0 in 2026.
- Business Quant data shows ARVN's Debt Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.47 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.26 |
| 10 | Arvinas | 609.77 Mn | 41.87 Mn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |